Peter W. White
Paraza Pharma (Canada)(CA)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Cervical Cancer and HPV Research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Discovery of Small-Molecule Inhibitors of the ATPase Activity of Human Papillomavirus E1 Helicase(2003)113 cited
- → Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection(2010)112 cited
- → Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease(2010)109 cited
- → Crystal Structure of the E2 Transactivation Domain of Human Papillomavirus Type 11 Bound to a Protein Interaction Inhibitor(2004)95 cited
- → Role of the ATP-Binding Domain of the Human Papillomavirus Type 11 E1 Helicase in E2-Dependent Binding to the Origin(1999)89 cited
- → Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)(2010)89 cited
- → Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcription(2020)85 cited
- → Sensitivity of NS3 Serine Proteases from Hepatitis C Virus Genotypes 2 and 3 to the Inhibitor BILN 2061(2004)84 cited
- → Inhibition of Human Papillomavirus DNA Replication by Small Molecule Antagonists of the E1-E2 Protein Interaction(2003)71 cited
- → Discovery of the first series of inhibitors of human papillomavirus type 11: inhibition of the assembly of the E1–E2–Origin DNA complex(2003)67 cited